Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hepatitis

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

Viral Hepatitis I: Introduction

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

Viruses with RNA Genomes

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...

Size and Structure of Viral Genomes

Size and Structure of Viral Genomes

Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Different Approaches for Thyroid Surgery.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India·2023

Same author

Long Term Survival of Patients Undergoing TIPS in Budd-Chiari Syndrome.

Journal of clinical and experimental hepatology·2019

Same author

Risk factors for inflammatory bowel disease: A prospective multi-center study.

Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology·2018

Same author

Management of Chronic Hepatitis B Infection in India.

The Journal of the Association of Physicians of India·2018

Same author

Natural History of Cirrhosis of Liver after First Decompensation: A Prospective Study in India.

Journal of clinical and experimental hepatology·2018

Same author

Inflammatory Bowel Disease Across the Age Continuum: Similarity and Disparity.

Indian journal of pediatrics·2018

Search research articles

Related Experiment Video

Updated: Jul 6, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Do different hepatitis C virus genotypes behave differently?

Deepak N Amarapurkar¹, Nikhil D Patel, Priyamvada Rane

¹Department of Gastroenterology, Bombay Hospital & Medical Research Centre, Mumbai. amarapurkar@gmail.com

Tropical Gastroenterology : Official Journal of the Digestive Diseases Foundation

|April 4, 2008

Summary

This summary is machine-generated.

Hepatitis C genotype III infection, common in India, showed a better treatment response compared to genotype I. Genotype III also had a higher, though not statistically significant, rate of steatosis.

More Related Videos

A Protocol for Analyzing Hepatitis C Virus Replication

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

Related Experiment Videos

Last Updated: Jul 6, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

A Protocol for Analyzing Hepatitis C Virus Replication

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

Area of Science:

Hepatology
Infectious Diseases
Virology

Background:

Hepatitis C genotype III is prevalent in India, but its natural history requires further understanding.
Limited data exists on the comparative natural history of Hepatitis C virus (HCV) genotypes III and I.

Purpose of the Study:

To compare the natural history of Hepatitis C virus (HCV) infection between genotype III and genotype I.
To evaluate differences in clinical presentation, treatment response, and complications between HCV genotypes.

Main Methods:

A 10-year prospective follow-up study involving 108 patients with Hepatitis C.
Patients were divided into two groups: 65 with genotype III and 43 with genotype I.
Data collected included demographics, clinical course, treatment response (interferon-ribavirin or peginterferon-ribavirin), and complications; analyzed using chi-square and Student's t-tests.

Main Results:

Steatosis was more frequent in genotype III (32.3%) than genotype I (18.6%), but not statistically significant.
No significant differences were observed in mode of infection, comorbidities, clinical presentation, extra-hepatic manifestations, liver disease stage, complications, or mortality.
Sustained treatment response was significantly higher in genotype III patients (87.5%) compared to genotype I patients (56.2%) (p = 0.0001).

Conclusions:

Hepatitis C virus (HCV) genotype III infection is associated with a superior treatment response.
A trend towards increased steatosis was noted in genotype III infections, warranting further investigation.